SCHEMBL22074019

SCHEMBL22074019

CCOC(=O)/C=C/c1cc2cc(OCc3ccccc3)cnc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
F13A1 P00488 1/20 0.41
TGM2 P21980 1/20 0.41
TGM1 P22735 1/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
MEN1 O00255 1/20 0.40
HSP90AA1 P07900 1/20 0.40
KMT2A Q03164 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS2 P35354 1/20 0.38
NR1H4 Q96RI1 1/20 0.37
CCNC P24863 1/20 0.37
CDK8 P49336 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
LMNA P02545 3/20 0.36
BCL2 P10415 1/20 0.36
BID P55957 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22077195 0.82 PDGFRB (0.40) MEN1KMT2ANPC1RAB9ABCL2
SCHEMBL23916331 0.81 NPC1 (0.46) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL23915873 0.79 EGFR (0.42) ALDH1A1EGFRERBB2MEN1HSP90AA1
SCHEMBL4309289 0.75 PTGDR2 (0.43) F13A1TGM2TGM1MEN1KMT2A
SCHEMBL6136951 0.72 LMNA (0.51) ALDH1A1EGFRERBB2MEN1HSP90AA1
SCHEMBL6136949 0.72 LMNA (0.51) ALDH1A1EGFRERBB2MEN1HSP90AA1
SCHEMBL2139517 0.72 NOD1 (0.64) ALDH1A1MEN1KMT2ALMNAL3MBTL1
SCHEMBL18376430 0.71 NOD2 (0.40) ALDH1A1NPC1RAB9APTGS2NOD2
SCHEMBL949756 0.71 SRD5A2 (0.52) EGFRERBB2MEN1HSP90AA1KMT2A
SCHEMBL949755 0.71 SRD5A2 (0.52) EGFRERBB2MEN1HSP90AA1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017513-A1 AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE SHANGHAI JEMINCARE PHARMACEUTICALS CO., LTD (CN) 2022-01-20 US disclosed
EP-3892616-A1 AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) 2021-10-13 EP disclosed
WO-2020114475-A1 AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE 上海济煜医药科技有限公司 2020-06-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017513-A1 AROMATIC RING DERIVATIVE AS IMMUNOREGULATION AND PREPARATION METHOD AND APPLICATION OF AROMATIC RING DERIVATIVE S1PR1, S1PR2, S1PR3 ALDH1A1 1752/4885F13A1 2239/4885TGM2 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.